Atlas Venture Life Science Advisors
Latest statistics and disclosures from Atlas Venture Life Science Advisors's latest quarterly 13F-HR filing:
- Top 5 stock holdings are KYMR, IRON, DYN, SION, KRRO, and represent 92.34% of Atlas Venture Life Science Advisors's stock portfolio.
- Added to shares of these 1 stock: Imagenebio.
- Started 1 new stock position in Imagenebio.
- Reduced shares in these 6 stocks: THRD (-$57M), VIGL (-$46M), Generation Bio (-$46M), IRON (-$16M), IKNA (-$6.7M), SION.
- Sold out of its positions in IKNA, THRD, VIGL.
- Atlas Venture Life Science Advisors was a net seller of stock by $-170M.
- Atlas Venture Life Science Advisors has $753M in assets under management (AUM), dropping by 13.63%.
- Central Index Key (CIK): 0001917529
Tip: Access up to 7 years of quarterly data
Positions held by Atlas Venture Life Science Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors holds 9 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Kymera Therapeutics Common Stock (KYMR) | 36.8 | $277M | 4.9M | 56.60 |
|
|
| Disc Medicine Common Stock (IRON) | 18.8 | $142M | -10% | 2.1M | 66.08 |
|
| Dyne Therapeutics Common Stock (DYN) | 15.3 | $116M | 9.1M | 12.65 |
|
|
| Sionna Therapeutics Common Stock (SION) | 14.1 | $106M | -2% | 3.6M | 29.41 |
|
| Korro Bio Common Stock (KRRO) | 7.2 | $55M | 1.1M | 47.89 |
|
|
| Day One Biopharmaceuticals Common Stock (DAWN) | 6.0 | $45M | 6.4M | 7.05 |
|
|
| Generation Bio Common Stock | 0.7 | $5.1M | -90% | 828k | 6.12 |
|
| Q32 Bio Common Stock (QTTB) | 0.6 | $4.1M | 2.1M | 1.98 |
|
|
| ImageneBio Common Stock | 0.4 | $3.1M | NEW | 378k | 8.15 |
|
Past Filings by Atlas Venture Life Science Advisors
SEC 13F filings are viewable for Atlas Venture Life Science Advisors going back to 2022
- Atlas Venture Life Science Advisors 2025 Q3 filed Nov. 13, 2025
- Atlas Venture Life Science Advisors 2025 Q2 filed Aug. 12, 2025
- Atlas Venture Life Science Advisors 2025 Q1 filed May 14, 2025
- Atlas Venture Life Science Advisors 2024 Q4 filed Feb. 6, 2025
- Atlas Venture Life Science Advisors 2024 Q3 filed Nov. 13, 2024
- Atlas Venture Life Science Advisors 2024 Q2 filed Aug. 9, 2024
- Atlas Venture Life Science Advisors 2024 Q1 filed May 6, 2024
- Atlas Venture Life Science Advisors 2023 Q4 filed Feb. 9, 2024
- Atlas Venture Life Science Advisors 2023 Q3 filed Nov. 13, 2023
- Atlas Venture Life Science Advisors 2023 Q2 filed Aug. 11, 2023
- Atlas Venture Life Science Advisors 2023 Q1 filed May 15, 2023
- Atlas Venture Life Science Advisors 2022 Q4 filed Feb. 14, 2023
- Atlas Venture Life Science Advisors 2022 Q3 filed Nov. 9, 2022
- Atlas Venture Life Science Advisors 2022 Q2 filed Aug. 3, 2022
- Atlas Venture Life Science Advisors 2021 Q4 filed May 16, 2022
- Atlas Venture Life Science Advisors 2022 Q1 filed May 16, 2022